Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexavar in non-smokers or light smokers with NSCLC
NCT00754923Phase 2Terminated
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Oct 2008
- Primary completion
- Apr 2012
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in non-small cell lung cancer (NSCLC), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Started Oct 2008; status: terminated.
02
Drugs
sorafenib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00754923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00754923.